|
Study Demonstrates a Significant Increase in Lung Nodule Detection With Riverain Medical's SoftView Chest X-ray Application
Posted on:
April 22, 2011
Riverain Medical announced the publication of a peer-reviewed study in Radiology demonstrating that radiologists using Riverain Medical's SoftView bone suppression application with chest X-rays significantly increased their detection of lung nodules proven to be primary lung cancer. SoftView enhanced chest imaging uses patent-pending machine learning and image-processing algorithms to suppress the ribs and clavicles that obscure nodules that may be early-stage lung cancer.
"It is encouraging to see a growing body of scientific work demonstrating the benefits of SoftView," the company stated. "Riverain Medical is committed to developing technology that can change the outcomes of patients by aiding in the detection of cancer at its earliest and most treatable stage."
The reader study, funded by Riverain Medical and conducted at Georgetown University in Washington, D.C., consisted of 15 radiologists analyzing 368 chest X-rays. The radiologists interpreted the standard chest X-ray to locate lung nodules and then reviewed the SoftView bone suppressed image. The authors concluded that "the radiologists using visualization software significantly increased their detection of lung cancers and benign nodules" than without this technology. In fact, 74 percent of the additional cancers found when reviewing the SoftView images were in hard-to-view areas with 70 percent or greater bone and nodule overlap. As a result, using SoftView helped clinicians decide whether to suggest additional diagnostic testing including CT and lung biopsy.
|
|
Daily News Watch Archives |
|
|
|